Is NAD+ a peptide, or a coenzyme?
10 min read · Updated October 2026 · MY PEPTIDES Research Team
Key facts
NAD+ is not a peptide. Nicotinamide adenine dinucleotide is a dinucleotide coenzyme: nicotinamide mononucleotide (NMN) joined to adenosine monophosphate (AMP) through a pyrophosphate bridge, formula C21H27N7O14P2, with no amino acids and no peptide bonds. The "+" marks the positive charge on its nicotinamide ring, not the charge of the whole molecule. NAD+ has two jobs in cells. As a redox coenzyme it accepts a hydride at carbon 4 of that ring to become NADH and is recycled. As a substrate it is consumed by sirtuins, PARPs and CD38, which split off nicotinamide and use the ADP-ribose part, so cells rebuild it continually, mainly through the NAMPT salvage route that also takes up NMN and nicotinamide riboside (NR). NAD+ is most fragile in alkaline solution and NADH in acid. MY PEPTIDES lists it as the NAD+ Kit; in the United States it is not an FDA-approved drug, has not been evaluated by the FDA, and is sold for in-vitro laboratory research only.
No: NAD+ is not a peptide. Nicotinamide adenine dinucleotide is a dinucleotide coenzyme, two nucleotides joined through their phosphates, and there is not a single amino acid or peptide bond anywhere in it. The question keeps coming up because NAD+ is sold by research-peptide suppliers (we list it as the NAD+ Kit) and "NAD peptide" has become a common search phrase. This guide treats NAD+ the way a chemist would: what the molecule is, what its plus sign means, how it carries electrons, which enzymes use it up, how cells make it, how it compares with the precursors NMN and NR, and what governs its stability on the bench.
Research use only. NAD+ is sold here for in-vitro laboratory research. It is not for human or veterinary use and has not been evaluated by the FDA. This page covers chemistry and cell biochemistry only.
NAD+ at a glance
| Property | NAD+ |
|---|---|
| Full name | Nicotinamide adenine dinucleotide, oxidized form |
| Chemical class | Pyridine dinucleotide coenzyme; not a peptide or protein |
| Molecular formula | C₂₁H₂₇N₇O₁₄P₂ |
| Formula weight | ≈663.4 g/mol as the free acid; salt forms weigh more |
| Building blocks | Nicotinamide mononucleotide (NMN) and adenosine monophosphate (AMP) |
| How they are joined | A pyrophosphate (phosphoanhydride) bridge between the two 5′ phosphates |
| Reactive site | Carbon 4 of the nicotinamide ring |
| Reduced partner | NADH, C₂₁H₂₉N₇O₁₄P₂ |
| Phosphorylated relative | NADP+, with one extra phosphate on the 2′ position of the adenosine ribose |
| Names in older papers | DPN (diphosphopyridine nucleotide), coenzyme I, cozymase |
Why "NAD peptide" is the wrong label
The words get attached by association: NAD+ comes from the same vendors, sits in the same freezers and comes up in the same online threads as research peptides. Chemically the two classes have almost nothing in common.
| A typical peptide | NAD+ | |
|---|---|---|
| Repeating unit | Amino acid residues | Two nucleotides |
| Main covalent links | Amide (peptide) bonds | One phosphoanhydride bond plus two N-glycosidic bonds |
| Sequence to confirm | Yes | None |
| Strongest UV feature | Amide backbone near 214 nm; 280 nm only if Trp or Tyr is present | 260 nm from the adenine ring |
| Typical weak point in water | Depends on sequence (for example Asn deamidation or Asp-Pro cleavage) | The nicotinamide-ribose glycosidic bond |
The label matters because it sets expectations about analysis. There is no sequence to read by tandem mass spectrometry and no amino acid composition to check. Identity for NAD+ rests on its mass, its UV spectrum and its chromatographic behavior, which are covered further down.
What the "+" in NAD+ means
The plus sign marks the positive charge on the ring nitrogen of nicotinamide in the oxidized form, which makes that ring a pyridinium ion. It is not the charge on the whole molecule. The pyrophosphate bridge carries two negative charges at neutral pH, so NAD+ as a whole sits at a net charge of about minus one. When the ring takes up a hydride it loses that positive charge, which is why the reduced form is written NADH with no plus sign. Many papers write "NAD" when the redox state does not matter, and "NAD(H)" or "NAD(P)H" when they mean both forms or both coenzymes.
From cozymase to NAD+: names in older literature
The molecule was found long before its structure was known. In 1906 Arthur Harden and William Young reported that fermentation in yeast juice depended on a small, heat-stable factor that passed through a dialysis membrane, and they called it cozymase. Hans von Euler-Chelpin went on to characterize it as a nucleotide, and he and Harden shared the 1929 Nobel Prize in Chemistry for their work on sugar fermentation. In the mid-1930s Otto Warburg's laboratory showed that the pyridine portion, the nicotinamide ring, is the part that carries hydrogen. Conrad Elvehjem's work in the same decade identified nicotinic acid and nicotinamide as the vitamin precursors of the coenzyme.
For decades the literature called NAD+ diphosphopyridine nucleotide (DPN) and NADP+ triphosphopyridine nucleotide (TPN). The current names replaced them during the 1960s, so a thorough search of older work needs both sets of terms.
Redox chemistry: a hydride on carbon 4
In its redox role NAD+ accepts two electrons and one proton, chemically a hydride ion, at carbon 4 of the nicotinamide ring. The product is NADH, and a second proton is released to solution:
NAD+ + 2e⁻ + H⁺ ⇌ NADH
Dehydrogenases catalyze this transfer, and each one delivers the hydride to one particular face of the flat ring, so the reaction is stereospecific. The standard reduction potential of the NAD+/NADH couple at pH 7 is about −0.32 V. The coenzyme is recycled rather than used up: it moves back and forth between the two forms as glycolysis, the TCA cycle and mitochondrial respiration oxidize their substrates, and the NAD+/NADH ratio is one of the most widely measured indicators of a cell's redox state.
Reduction also changes the spectrum, which is the single most useful practical fact about the molecule. Both forms absorb at 260 nm through the adenine ring. Only NADH absorbs at 340 nm, with a molar absorptivity of about 6,220 M⁻¹ cm⁻¹, and only NADH fluoresces, emitting around 460 nm when excited at 340 nm. Classic enzyme assays follow dehydrogenase reactions by watching that 340 nm band rise or fall, and a preparation sold as NAD+ that shows meaningful absorbance at 340 nm contains reduced material.
NADP+ uses the same ring and the same chemistry, and its standard potential is nearly identical. The extra 2′-phosphate, added to NAD+ by the enzyme NAD kinase, is a recognition tag that lets enzymes tell the two coenzymes apart. Cells exploit that difference by keeping the NAD pool largely oxidized and the NADP pool largely reduced, so NAD+ mostly accepts electrons from catabolic pathways while NADPH mostly donates them to biosynthesis and to the glutathione system.
Recycled or consumed: the second job of NAD+
The redox role leaves NAD+ intact. A second group of enzymes destroys it. They break the bond between nicotinamide and its ribose, release free nicotinamide, and put the ADP-ribose part to use:
| Enzyme family | What it does with NAD+ | Main products besides nicotinamide |
|---|---|---|
| Sirtuins | Removes acetyl and other acyl groups from protein lysines, using NAD+ as co-substrate | 2′-O-acyl-ADP-ribose and the deacylated protein |
| PARPs | Transfers ADP-ribose onto proteins; PARP1 and PARP2 build branched poly(ADP-ribose) chains, many others add a single unit | Mono- or poly(ADP-ribosyl)ated proteins |
| CD38, and the related CD157 | Hydrolyzes NAD+ and, to a smaller extent, cyclizes it | ADP-ribose and cyclic ADP-ribose |
Each turnover of these enzymes spends one NAD+ molecule that the cell then has to rebuild. That is why the NAD+ level in a culture is better treated as the balance between synthesis and consumption than as a fixed quantity, and why an assay of a consuming enzyme depends on how much intact NAD+ was present at the start. Nicotinamide, the shared by-product, is itself an inhibitor of sirtuins, a detail worth controlling for in deacylation assays.
Routes into the NAD+ pool
Cells can build NAD+ from several starting points, and the routes meet at a common step:
| Route | Starting material | First enzyme | Where it joins |
|---|---|---|---|
| Nicotinamide salvage | Nicotinamide, including the nicotinamide released by consuming enzymes | NAMPT, making NMN | NMNAT joins NMN to AMP from ATP, giving NAD+ |
| Nicotinamide riboside branch | Nicotinamide riboside (NR) | NRK1 or NRK2, making NMN | The same NMNAT step |
| Preiss-Handler | Nicotinic acid | NAPRT, making nicotinic acid mononucleotide | NMNAT, then NAD synthetase converts the acid form to NAD+ |
| De novo | Tryptophan, through kynurenine and quinolinic acid | QPRT, making nicotinic acid mononucleotide | Same as Preiss-Handler |
Two papers from 2004 anchor the salvage side. Working in mouse fibroblasts, Revollo and colleagues found NAMPT to be the rate-limiting component of the nicotinamide route: raising NAMPT, but not NMNAT, increased total cellular NAD. In the same year Bieganowski and Brenner showed that nicotinamide riboside is an NAD+ precursor through dedicated nicotinamide riboside kinases conserved from yeast to humans, a route that does not pass through nicotinic acid mononucleotide. Humans have three NMNAT enzymes, NMNAT1 to NMNAT3, located mainly in the nucleus, the Golgi and cytosol, and mitochondria respectively.
NAD+, NMN and NR as chemicals
The three names travel together, but they are different compounds at different points in the same network:
| Nicotinamide riboside (NR) | Nicotinamide mononucleotide (NMN) | NAD+ | |
|---|---|---|---|
| Class | Nucleoside | Mononucleotide | Dinucleotide |
| Phosphate groups | None | One | Two, as a pyrophosphate |
| Formula weight | ≈255.2 (the cation; usually handled as the chloride salt) | ≈334.2 | ≈663.4 |
| Enzymatic steps to NAD+ | Two: NRK, then NMNAT | One: NMNAT | None |
| Adenine present | No | No | Yes |
For in-vitro work the differences are physical as much as biological. The three differ in size, in charge and in how they cross membranes, so a cell's response to one depends on transport and on its conversion machinery, not just on the end product. Their spectra differ too: NR and NMN lack the adenine ring, so their absorbance near 260 nm comes from nicotinamide alone and is much weaker than that of NAD+, and a concentration calibrated for one cannot be read across to the others. A result obtained with NR or NMN describes that compound and the cell's capacity to convert it; it is not a result about NAD+ added directly.
Compartments: one molecule, several pools
A cell's NAD+ is not one well-mixed pool. The nucleus and cytosol exchange freely through nuclear pores, while mitochondria hold a separate pool behind an inner membrane that NADH cannot cross. Reducing equivalents made in the cytosol reach the mitochondria indirectly, through the malate-aspartate and glycerol-3-phosphate shuttles.
Whether mammalian mitochondria can import intact NAD+ was argued for years. In 2020 the carrier SLC25A51 was identified as a mammalian mitochondrial NAD+ transporter; cells lacking it had less mitochondrial NAD+ while whole-cell NAD+ was unchanged. The practical point for experimental design is that a whole-cell NAD+/NADH figure averages compartments that can sit at very different ratios, which is why genetically encoded sensors targeted to individual compartments have become common in the field.
Stability as chemistry
NAD+ is less robust than its central role might suggest, and its reduced form is fragile under the opposite conditions:
- pH. The oxidized form is most vulnerable in alkaline solution, where hydroxide attacks the positively charged nicotinamide ring and the nicotinamide-ribose bond breaks, releasing nicotinamide and ADP-ribose. NADH is the mirror image: acid catalyzes the addition of water across its reduced ring, and breakdown speeds up as pH falls. Kinetic work on NADPH and NADH found the degradation rate tracks hydronium ion concentration and temperature.
- Buffer identity. The buffer species matters as well as the pH. The same kinetic study found that phosphate and acetate accelerate loss of the reduced cofactors, and a 2024 comparison running for 43 days found both NAD+ and NADH highly stable in Tris, with faster NADH loss in sodium phosphate and HEPES.
- Temperature. Rates climb with temperature. In the 2024 study, even the step from 19 °C to 25 °C made a significant difference to long-term NADH stability.
- Light. NADH absorbs in the near-ultraviolet, and protecting the reduced form from strong light is routine bench practice.
- Hydrolysis by other routes. The pyrophosphate bridge can also be cleaved, chemically or by nucleotide pyrophosphatases present in biological extracts, giving NMN and AMP.
None of this is visible. A degraded NAD+ solution looks the same as a fresh one, so the checks are spectroscopic and chromatographic: absorbance at 340 nm for reduced contamination, and reversed-phase HPLC for nicotinamide and ADP-ribose peaks that elute separately from the parent.
What a certificate for NAD+ should show
- Chromatographic purity by reversed-phase HPLC with UV detection at 260 nm, ideally with the chromatogram rather than a bare percentage.
- Identity that fits a dinucleotide: a mass consistent with the stated salt form, and a UV spectrum peaking near 260 nm with little or nothing at 340 nm.
- The salt form named, free acid or sodium salt, since it changes the formula weight and so the meaning of any stated mass.
- A batch number that matches the container, with the analysis date.
Our batch certificates are published in the COA library, and the Certificate of Analysis guide explains how to read one.
NAD+ supply in the United States
The NAD+ Kit is dispatched cold-chain from the warehouse that serves the United States, with tracked delivery across the country next business day. It is priced in US dollars and payable by Visa, Mastercard or Apple Pay, and its batch certificate is in the COA library. This guide does not describe the kit's packaging or contents; if those details matter to your protocol, contact support before ordering, and follow the storage statement on the container.
Regulatory position
The NAD+ we supply is not an FDA-approved drug, has not been evaluated by the FDA and is not sold as a dietary supplement. It is a research material for in-vitro laboratory work only and is not for human or veterinary use.
What this page leaves out
This guide gives no amounts, schedules or preparation-for-use instructions and does not discuss any use of NAD+ in people or animals. We supply research materials; we are not a clinic.
Related reading
NAD+ Kit
Available now from MY PEPTIDES — 99%+ purity, COA with every order, fast US shipping.
Frequently asked questions
- Is NAD+ a peptide?
- No. NAD+ (nicotinamide adenine dinucleotide) is a dinucleotide coenzyme: NMN and AMP linked by a pyrophosphate bridge. It contains no amino acids and no peptide bonds. It turns up in peptide catalogs because the same laboratories often buy both.
- Why do people call it "NAD peptide"?
- Because it is sold by research-peptide suppliers and discussed alongside peptides, so the word has stuck by association. Chemically the label is wrong, and it leads to the wrong expectations: there is no sequence to confirm, and identity is checked by mass, UV absorbance and chromatography rather than by peptide methods.
- What does the + in NAD+ mean?
- It marks the positive charge on the nitrogen of the nicotinamide ring in the oxidized form. It is not the net charge of the molecule: the two phosphate groups are negatively charged at neutral pH, so NAD+ carries a net charge of about minus one. The reduced form, NADH, has lost the ring charge.
- What is the difference between NAD+ and NADH?
- They are the oxidized and reduced forms of one coenzyme. NAD+ takes up a hydride at carbon 4 of its nicotinamide ring and becomes NADH; NADH gives it up and returns to NAD+. Only NADH absorbs at 340 nm and fluoresces. The two also break down under opposite conditions: NAD+ in alkali, NADH in acid.
- How are NAD+, NMN and NR related?
- They are steps in the same salvage network. Nicotinamide riboside (NR) is a nucleoside; a kinase phosphorylates it to nicotinamide mononucleotide (NMN); NMNAT enzymes then join NMN to the AMP part of ATP to make NAD+. They differ in size, charge and spectrum, so a result with one does not stand in for the others.
- Which enzymes use up NAD+?
- Sirtuins, PARPs and CD38, along with the related CD157. Each cleaves the bond between nicotinamide and ribose, releasing nicotinamide and using the ADP-ribose part, so the NAD+ is consumed and has to be rebuilt, mainly through the NAMPT salvage route. This is studied in biochemical and cell systems.
- How is NAD+ purity checked?
- Reversed-phase HPLC with detection at 260 nm gives a purity figure and shows breakdown products such as nicotinamide and ADP-ribose. Absorbance at 340 nm flags reduced NADH. A mass spectrum should match the stated salt form. A batch certificate should report these for the lot in hand.
- Is NAD+ FDA-approved?
- The NAD+ we supply is not an FDA-approved drug and has not been evaluated by the FDA. It is sold for in-vitro laboratory research only and is not for human or veterinary use.
Related products
Continue reading
Sources
- Covarrubias et al. (2021), Nat Rev Mol Cell Biol — review of NAD+ metabolism, biosynthesis and NAD+-consuming enzymes
- Revollo, Grimm & Imai (2004), J Biol Chem — NAMPT as the rate-limiting step of nicotinamide salvage
- Bieganowski & Brenner (2004), Cell — nicotinamide riboside kinases and the NR route to NAD+
- Xiao et al. (2018), Antioxid Redox Signal — review of the NAD(H) and NADP(H) redox couples and their compartmentalized pools
- Luongo et al. (2020), Nature — SLC25A51 as a mammalian mitochondrial NAD+ transporter
- Wu, Wu & Knight (1986), Clin Chem — degradation kinetics of NADPH and NADH (pH, temperature, phosphate, acetate)
- Wolfe et al. (2024), Molecules — long-term stability of NAD+ and NADH in phosphate, HEPES and Tris buffers